temozolomide has been researched along with Hemangiosarcoma in 1 studies
Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weidema, ME | 1 |
| Desar, IME | 1 |
| Hillebrandt-Roeffen, MHS | 1 |
| van Erp, AEM | 1 |
| Masuzawa, M | 1 |
| Flucke, UE | 1 |
| van der Graaf, WTA | 1 |
| Versleijen-Jonkers, YMH | 1 |
1 other study available for temozolomide and Hemangiosarcoma
| Article | Year |
|---|---|
PARP inhibition in UV-associated angiosarcoma preclinical models.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Proliferation; Drug Combinations; Drug Evaluation | 2021 |